US · PLYX
Polaryx Therapeutics, Inc. Common Stock
- Sector
- Healthcare · Biotechnology
- Headquarters
- Paramus, NJ 07652
- Website
- polaryx.com
Price at previous close
$2.81
Market cap 156.78M
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| PLYX | Polaryx Therapeutics, Inc… | $2.81 | 156.78M | — | — | — | — | — | — | — | — | — |
| ANTX | AN2 Therapeutics, Inc. | $4.46 | 122.21M | — | — | — | — | -0.76 | 0.48 | — | -13.78 | — |
| CBIO | Crescent Biopharma, Inc. | $21.47 | 591.97M | — | -63% | — | — | -7.78 | 5.75 | — | -6.38 | — |
| FHTX | Foghorn Therapeutics Inc. | $4.27 | 250.71M | — | — | — | — | — | — | — | — | — |
| HCWB | HCW Biologics Inc. | $2.09 | 4.36M | — | — | — | +15,408% | — | — | — | — | — |
| JBIO | Jade Biosciences, Inc. | $20.84 | 679.92M | — | — | — | — | -1.01 | 0.92 | — | 0.11 | — |
| KLRS | Kalaris Therapeutics Inc | $5.18 | 96.88M | — | — | — | — | -0.84 | 0.44 | — | 1.17 | — |
| KZR | Kezar Life Sciences, Inc. | $7.29 | 53.86M | +354% | — | — | — | -5.31 | 3.80 | — | -4.05 | -10000.00% |
| LYEL | Lyell Immunopharma, Inc. | $16.83 | 392.71M | — | — | — | +2,866% | — | — | — | — | — |
| NXTC | NextCure, Inc. | $6.40 | 17.15M | — | — | — | — | -0.38 | 0.32 | — | 0.77 | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $2.81) − 1 = — (DCF, example).